Skip to main content

Table 4 Patient acceptance and adverse events

From: Cytologic features of nipple aspirate fluid using an automated non-invasive collection device: a prospective observational study

 

Initial (n = 500)

Post-procedure survey (n = 419)

HALO comfort assessment (scale 0–10)

5.0

4.2

Redness post HALO

No. (%)

No. (%)

   None

130 (26.0)

0

   Mild

297 (59.4)

0

   Moderate

71 (14.2)

0

   Severe

2 (0.4)

0

Would recommend HALO to others

N/A

367 (87.6)

Would choose HALO again

N/A

349 (83.3)